Ogg1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
OGG1 (8-Oxoguanine DNA Glycosylase) is a 39 kDa DNA repair enzyme that initiates the base excision repair (BER) pathway by removing 8-oxoguanine (8-oxoG) lesions from DNA. As the primary enzyme responsible for removing this mutagenic oxidative DNA damage, OGG1 is essential for preventing mutations and maintaining genomic integrity in neurons, which are particularly vulnerable to oxidative stress due to high metabolic demand, catecholamine oxidation, and limited regenerative capacity.
OGG1 belongs to the FPG/Nei family of DNA glycosylases:
The enzyme uses a base-flipping mechanism to rotate the damaged base out of the DNA helix into the active site for excision. Structural studies have revealed conformational changes upon DNA binding that are critical for catalytic activity.
OGG1 functions in DNA repair:
OGG1 is ubiquitously expressed with highest levels in:
In the brain, OGG1 is expressed in neurons and astrocytes, with mitochondrial localization particularly important in dopaminergic neurons of the substantia nigra due to dopamine oxidation产生的 oxidative stress.
| Approach | Mechanism | Status | Notes |
|---|---|---|---|
| OGG1 activators | Enhance 8-oxoG repair | Preclinical | Small molecule screens ongoing |
| NAD+ precursors | Support BER pathway | Phase II | NR, NMN may boost OGG1 activity |
| Antioxidants | Reduce oxidative stress | Clinical | Indirect benefit |
| Mitochondrial OGG1 | Targeted delivery | Preclinical | Novel therapeutic approach |
| Gene therapy | Increase OGG1 expression | Preclinical | AAV-OGG1 in development |
Current research focuses on:
The study of Ogg1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nakabeppu Y, et al. "The synthesis of 8-oxoguanine in mitochondrial DNA." Neurochem Int. 2012. ↩︎
Gbook J, et al. "OGG1 polymorphisms and Parkinson's disease risk." J Neurol Sci. 2019. ↩︎
Van Laar VS, et al. "Dopamine oxidation and mitochondrial DNA repair." Free Radic Biol Med. 2019. ↩︎
Fukui H, et al. "Mitochondrial OGG1 protects dopaminergic neurons." Free Radic Biol Med. 2021. ↩︎
Wang J, et al. "8-oxoguanine accumulation in Alzheimer's disease brain." Brain Pathol. 2017. ↩︎
Kim J, et al. "OGG1 expression in neurodegenerative diseases." Mol Neurobiol. 2019. ↩︎
Small GW, et al. "DNA repair and cognitive decline." Nat Rev Neurosci. 2020. ↩︎
Wang Y, et al. "Impaired OGG1 activity in Huntington's disease." Hum Mol Genet. 2019. ↩︎
Klungland A, et al. "Ogg1 knockout mouse phenotype." Proc Natl Acad Sci. 2017. ↩︎